Business
AGM Statement
AGM Statement.
About this update from Aura Renewable Acquisitions Plc
[{"type":"text","content":"\n Ardana PLC\n11 October 2006\n\n\n\n Ardana plc\n\n Annual General Meeting\n\n\nEdinburgh, UK, 11 October 2006 - Ardana plc (LSE: ARA.L) confirms that all\nresolutions put to the Annual General Meeting on 11 October 2006 were duly\npassed.\n\n\nEnquiries:\n\n\n\nArdana plc\n+44 (0)131 226 8558\nDr Maureen Lindsay, Chief Executive Officer\nGraham Lee, Chief Financial Officer\n\n\n\nFinancial Dynamics\n+44 (0)20 7831 3113\nJulia Phillips\nJohn Gilbert\n\n\n\nAbout Ardana\n\nArdana plc is a pharmaceutical company focused on the discovery, development and\nmarketing of innovative products to improve human reproductive health, a $25.5\nbillion market.\n\n\n\nSince its foundation, Ardana has maintained a broad and balanced portfolio to\nmanage risk and actively pursues product and technology in-licensing and\nout-licensing to maintain a robust pipeline.\n\n\n\nArdana's lead products are summarised below:\n\n\n\n • Emselex(R), a treatment for overactive bladder for which Ardana has sole\n and exclusive promotion rights in the UK and will be launched in\n collaboration with Novartis Pharmaceuticals UK Limited;\n • StriantSR, a testosterone replacement therapy for which Ardana has\n marketing rights in Europe, has been launched by Ardana through its own\n sales force in the UK and partners in various European countries, as a\n treatment for men with confirmed hypogonadism;\n • Teverelix LA, in development for three initial indications: prostate\n cancer and benign prostatic hyperplasia (both indications are at the phase\n II stage), and endometriosis (currently in phase I);\n • Testosterone Cream, a transdermal testosterone delivery system in phase II\n for the treatment of male hypogonadism;\n • Invicorp(R), an injectable combination drug treatment for erectile\n dysfunction, already approved in Denmark and for which Ardana has marketing\n and manufacturing rights in Europe. Launch is expected in H2 2006;\n\n\n\nIn addition, Ardana has a strong portfolio of follow-on products in development.\n\n\n\n\nFor further information please see www.ardana.co.uk\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange \n ","length":2313,"tagName":"div"}]